Cytokine Biomarkers of Disease Activity and Therapeutic Response after Initiating Methotrexate Therapy in Patients with Juvenile Idiopathic Arthritis-Reference-Cited by-同舟云学术

Cytokine Biomarkers of Disease Activity and Therapeutic Response after Initiating Methotrexate Therapy in Patients with Juvenile Idiopathic Arthritis

Published:2017-06 Issue:6 Volume:37 Page:700-711
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Funk Ryan S.¹²,Chan Marcia A.³,Becker Mara L.²⁴

Affiliation:

1. Department of Pharmacy Practice; University of Kansas Medical Center; Kansas City Kansas

2. Division of Clinical Pharmacology and Therapeutic Innovation; Children's Mercy Kansas City; Kansas City Missouri

3. Division of Allergy, Asthma and Immunology; Children's Mercy Kansas City; Kansas City Missouri

4. Division of Rheumatology; Children's Mercy Kansas City; Kansas City Missouri

Funder

Rheumatology Research Foundation

Children's Mercy Hospital

National Institute of Child Health and Human Development

Publisher

Wiley

Subject

Pharmacology (medical)

Link

Reference48 articles.

3. Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis;Albers;Arthritis Rheum,2009

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

3. Juvenile Idiopathic Arthritis;Orthopaedics for the Newborn and Young Child;2023